APA

Shimizu Y., Tanaka E., Inoue E., Shidara K., Sugimoto N., Seto Y., Nakajima A., Momohara S., Taniguchi A. & Yamanaka H. (20180827). Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. : Modern rheumatology.

Chicago

Shimizu Yoko, Tanaka Eiichi, Inoue Eisuke, Shidara Kumi, Sugimoto Naoki, Seto Yohei, Nakajima Ayako, Momohara Shigeki, Taniguchi Atsuo and Yamanaka Hisashi. 20180827. Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. : Modern rheumatology.

Harvard

Shimizu Y., Tanaka E., Inoue E., Shidara K., Sugimoto N., Seto Y., Nakajima A., Momohara S., Taniguchi A. and Yamanaka H. (20180827). Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. : Modern rheumatology.

MLA

Shimizu Yoko, Tanaka Eiichi, Inoue Eisuke, Shidara Kumi, Sugimoto Naoki, Seto Yohei, Nakajima Ayako, Momohara Shigeki, Taniguchi Atsuo and Yamanaka Hisashi. Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort. : Modern rheumatology. 20180827.